Challenges and Opportunities in the Care of Hematopoietic Cell Transplant Survivors in the Modern Era
Authors:
- 10 June 2025
- book chapter
- Published by Springer Nature
- Vol. 1475, 209-226
Abstract
With the constantly changing field of hematopoietic cell transplant (HCT) and cellular therapy and a growing number of survivors, there is an ongoing need for work to understand the changing landscape of late effects and develop interventions to optimize the long-term outcomes of survivors. In this chapter, we summarize the studies published in last 5 years describing late effects after HCT. We specifically discuss the available literature or the lack thereof for the late effects as it relates to the changes in transplant practices such as increased use of post-transplant cyclophosphamide, newer drugs to treat chronic graft vs. host disease, and chimeric antigen receptor T-cell therapy as a bridge to HCT or for a post-HCT relapse. We also summarize the recently updated recommendations for screening and management of late effects and a monitoring plan to cater to late effects specific to patients undergoing transplants for non-malignant diseases. We discuss the specific considerations such as challenges for adolescent and young adult HCT survivors, especially as they transition from pediatric to adult care. With the information discussed here, we outline challenges and opportunities for research and clinical practice highlighting the role of health care delivery models in addressing some of these issues.Keywords
This publication has 118 references indexed in Scilit:
- Comparison of long‐term outcomes between imatinib and dasatinib prophylaxis after allogeneic stem cell transplantation in patients with Philadelphia‐positive acute lymphoblastic leukemia: A multicenter retrospective studyCancer, 2024
- Health care utilization by long‐term survivors of blood or marrow transplantation—A Bone Marrow Transplant Survivor Study reportCancer, 2023
- Managing Survivorship after Hematopoietic Cell TransplantationCurrent Hematologic Malignancy Reports, 2023
- Psychological and physical function in allogeneic hematopoietic cell transplant survivors with chronic graft-versus-host diseaseJournal of Cancer Survivorship, 2023
- Trends in Late Mortality and Life Expectancy After Allogeneic Blood or Marrow Transplantation Over 4 DecadesJAMA Oncology, 2021
- Late‐occurring infections in a contemporary cohort of hematopoietic cell transplantation survivorsCancer Medicine, 2021
- Evaluation of Second Solid Cancers After Hematopoietic Stem Cell Transplantation in European PatientsJAMA Oncology, 2019
- Post‐transplantation employment status of adult survivors of childhood allogeneic hematopoietic cell transplant: A report from the Center for International Blood and Marrow Transplant Research (CIBMTR)Cancer, 2018
- Understanding care and outcomes in adolescents and young adults with cancer: A review of the AYA HOPE studyPediatric Blood & Cancer, 2018
- An online randomized controlled trial, with or without problem-solving treatment, for long-term cancer survivors after hematopoietic cell transplantationJournal of Cancer Survivorship, 2018